JP2014193892A5 - - Google Patents

Download PDF

Info

Publication number
JP2014193892A5
JP2014193892A5 JP2014101360A JP2014101360A JP2014193892A5 JP 2014193892 A5 JP2014193892 A5 JP 2014193892A5 JP 2014101360 A JP2014101360 A JP 2014101360A JP 2014101360 A JP2014101360 A JP 2014101360A JP 2014193892 A5 JP2014193892 A5 JP 2014193892A5
Authority
JP
Japan
Prior art keywords
affinity chromatography
ligand
amino acid
domains
spa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014101360A
Other languages
English (en)
Japanese (ja)
Other versions
JP6018120B2 (ja
JP2014193892A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014193892A publication Critical patent/JP2014193892A/ja
Publication of JP2014193892A5 publication Critical patent/JP2014193892A5/ja
Application granted granted Critical
Publication of JP6018120B2 publication Critical patent/JP6018120B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014101360A 2011-06-08 2014-05-15 新規なスタフィロコッカス・アウレウス(Staphylococcusaureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス Active JP6018120B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161494701P 2011-06-08 2011-06-08
US61/494,701 2011-06-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012124067A Division JP5756428B2 (ja) 2011-06-08 2012-05-31 新規なスタフィロコッカス・アウレウス(Staphylococcusaureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016140214A Division JP6189493B2 (ja) 2011-06-08 2016-07-15 新規なスタフィロコッカス・アウレウス(Staphylococcus aureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス

Publications (3)

Publication Number Publication Date
JP2014193892A JP2014193892A (ja) 2014-10-09
JP2014193892A5 true JP2014193892A5 (OSRAM) 2015-07-16
JP6018120B2 JP6018120B2 (ja) 2016-11-02

Family

ID=46229293

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012124067A Active JP5756428B2 (ja) 2011-06-08 2012-05-31 新規なスタフィロコッカス・アウレウス(Staphylococcusaureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス
JP2014101360A Active JP6018120B2 (ja) 2011-06-08 2014-05-15 新規なスタフィロコッカス・アウレウス(Staphylococcusaureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス
JP2016140214A Active JP6189493B2 (ja) 2011-06-08 2016-07-15 新規なスタフィロコッカス・アウレウス(Staphylococcus aureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス
JP2017148843A Active JP6586131B2 (ja) 2011-06-08 2017-08-01 新規なスタフィロコッカス・アウレウス(Staphylococcus aureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012124067A Active JP5756428B2 (ja) 2011-06-08 2012-05-31 新規なスタフィロコッカス・アウレウス(Staphylococcusaureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016140214A Active JP6189493B2 (ja) 2011-06-08 2016-07-15 新規なスタフィロコッカス・アウレウス(Staphylococcus aureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス
JP2017148843A Active JP6586131B2 (ja) 2011-06-08 2017-08-01 新規なスタフィロコッカス・アウレウス(Staphylococcus aureus)プロテインAベースのリガンドを含むクロマトグラフィーマトリックス

Country Status (13)

Country Link
US (5) US8754196B2 (OSRAM)
EP (2) EP2532672B1 (OSRAM)
JP (4) JP5756428B2 (OSRAM)
KR (3) KR101464040B1 (OSRAM)
CN (2) CN102895960B (OSRAM)
AU (3) AU2012366229C1 (OSRAM)
DK (2) DK2532672T3 (OSRAM)
ES (2) ES2710204T3 (OSRAM)
IL (2) IL229774A (OSRAM)
RU (2) RU2644680C1 (OSRAM)
SG (3) SG186552A1 (OSRAM)
TW (3) TWI596108B (OSRAM)
WO (1) WO2013109302A2 (OSRAM)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
CA3187687A1 (en) 2007-09-14 2009-03-19 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG186552A1 (en) * 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2013081540A1 (en) * 2011-11-30 2013-06-06 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
JP6182210B2 (ja) 2012-06-29 2017-08-16 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質精製プロセス中のウイルスの不活性化方法
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
CN104768536B (zh) 2012-09-17 2019-03-29 格雷斯公司 官能化微粒状载体材料和其制备和使用方法
ES2735354T3 (es) 2013-03-14 2019-12-18 Emd Millipore Corp Métodos para aumentar la pureza de proteínas utilizando la cromatografía basada en proteína A
CN105377880B (zh) * 2013-07-10 2020-08-07 通用电气医疗集团生物工艺研发股份公司 突变的免疫球蛋白结合多肽
ES2737078T3 (es) * 2013-09-04 2020-01-10 Emd Millipore Corp Cromatografía de Proteína A
PL3094390T3 (pl) 2014-01-16 2021-12-06 W.R. Grace & Co. - Conn. Nośniki do chromatografii powinowactwa i urządzenia do chromatografii
PL3137209T3 (pl) 2014-05-02 2023-01-02 W.R. Grace & Co. - Conn. Funkcjonalizowany materiał nośnikowy i sposoby wytwarzania oraz stosowania funkcjonalizowanego materiału nośnikowego
ES2920381T3 (es) * 2014-08-15 2022-08-03 Merck Patent Gmbh Purificación de inmunoglobulinas a partir de plasma
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN104399283B (zh) * 2014-12-04 2016-02-17 江西省农业科学院农产品质量安全与标准研究所 黄曲霉毒素b1适配体亲和柱的制备方法
CN104645949B (zh) * 2015-02-04 2017-01-25 浙江大学 一种以四肽为功能配基的亲和层析介质及其制备方法
JP6805831B2 (ja) 2015-02-05 2020-12-23 三菱ケミカル株式会社 免疫グロブリンに親和性を有するタンパク質、およびそれを用いたアフィニティ分離剤、液体クロマトグラフィー用カラム
DK3253785T3 (da) 2015-02-06 2019-07-08 Navigo Proteins Gmbh Hidtil ukendte egfr-bindingsproteiner
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
CN107429244A (zh) * 2015-03-26 2017-12-01 Jsr株式会社 免疫球蛋白结合蛋白质和使用其的亲和载体
KR20170121746A (ko) * 2015-04-13 2017-11-02 후지필름 가부시키가이샤 단쇄 펩타이드 고정화 담체의 제조 방법 및 단쇄 펩타이드 고정화 담체
US10695744B2 (en) 2015-06-05 2020-06-30 W. R. Grace & Co.-Conn. Adsorbent biprocessing clarification agents and methods of making and using the same
ES2916101T3 (es) 2015-07-16 2022-06-28 Navigo Proteins Gmbh Nuevas proteínas de unión a inmunoglobulina y su uso en la purificación por afinidad
JP2018520675A (ja) 2015-07-20 2018-08-02 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングNavigo Proteins GmbH ジユビキチン変異タンパク質をベースとした新規結合タンパク質及びその生成方法
GB201515339D0 (en) * 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US10697983B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US20170066839A1 (en) 2015-09-08 2017-03-09 Merck Patent Gmbh Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies
CN105413644A (zh) * 2015-12-02 2016-03-23 南昌大学 基于特异结合黄曲霉毒素单域重链抗体的亲和吸附材料
KR101993845B1 (ko) * 2016-02-18 2019-06-28 (주)에이피테크놀로지 알칼리 저항성이 증대된 항체 친화성 리간드
AU2017260274A1 (en) 2016-05-04 2018-11-01 Navigo Proteins Gmbh Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
ES2914278T3 (es) * 2016-05-11 2022-06-08 Cytiva Bioprocess R & D Ab Polipéptidos de unión a inmunoglobulina mutados
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
KR101857953B1 (ko) * 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
AU2017311542B2 (en) 2016-08-11 2021-06-24 Repligen Corporation Alkaline stable Fc—binding proteins for affinity chromatography
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
EP3551646A1 (en) 2016-12-12 2019-10-16 HurraH S.à r.l. Compositions and methods for increasing the immunoglobulin binding capacities of immunoglobulin-binding polypeptides and oligopeptides
CN106596822B (zh) * 2016-12-16 2018-01-19 南京市产品质量监督检验院 一种食品中金黄色葡萄球菌苯酚可溶性调控蛋白的检测方法
GB201708277D0 (en) 2017-05-24 2017-07-05 Ge Healthcare A Recombinant protein
EP4491268A3 (en) 2017-08-07 2025-04-09 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
EP3521304B9 (en) 2018-02-01 2023-10-04 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
WO2019091918A1 (en) 2017-11-07 2019-05-16 Navigo Proteins Gmbh Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of cancer
WO2019093439A1 (ja) 2017-11-09 2019-05-16 東ソー株式会社 免疫グロブリン結合性タンパク質
US20210130395A1 (en) * 2018-05-11 2021-05-06 William Marsh Rice University Proximity induced site-specific antibody conjugation
KR102055708B1 (ko) 2018-06-26 2019-12-13 동일플랜트 주식회사 스팀 배기관에 삽입된 히트파이프를 이용한 드래프트 방식 복수기
EP3842536A4 (en) 2018-08-24 2023-01-18 JSR Corporation IMMUNOGLOBULIN BINDING PROTEIN AND AFFINITY SUPPORT USING THE SAME
GB201904125D0 (en) 2019-03-26 2019-05-08 Ge Healthcare Bio Sciences Ab Method for sanitization of a chromatography column
CN112210013A (zh) * 2019-07-03 2021-01-12 拜奥普罗塞亚科技有限责任公司 碱耐受性亲和色谱配体
CN114667450B (zh) * 2019-09-24 2025-05-02 里珍纳龙药品有限公司 用于色谱介质的使用和再生的系统及方法
EP3875472A1 (en) * 2020-03-06 2021-09-08 Navigo Proteins Gmbh Novel immunoglobulin binding polypeptides
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
GB202203478D0 (en) 2022-03-14 2022-04-27 Cytiva Bioprocess R & D Ab Vh3 binding polypeptides
CN115850408A (zh) * 2022-09-01 2023-03-28 西安蓝晓科技新材料股份有限公司 一种多肽、融合型多聚体蛋白质及其用途

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462046C (sv) 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
US5151350A (en) 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4617266A (en) 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
NZ218050A (en) 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US5260373A (en) 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5084559A (en) 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5089473A (en) 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
GB8902770D0 (en) 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to supports for immunoaffinity separations
US4879378A (en) 1989-03-30 1989-11-07 Union Carbide Chemicals And Plastics Company Inc. Polysiloxanes with pendant sterically hindered phenol moiety connected to the silicon atom via a carbonylyoxy-containing link
US5401650A (en) 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
US5198531A (en) 1991-06-14 1993-03-30 Research Diagnostic Antibodies Polymeric resin for peptide synthesis
EP0863210A3 (en) 1991-07-25 1999-09-22 Oriental Yeast Co., Ltd. Immunoglobulin-binding artificial protein
US5240680A (en) 1991-12-19 1993-08-31 Chiron Corporation Automated apparatus for use in peptide synthesis
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
SE9503925D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
WO1997036614A1 (en) 1996-03-29 1997-10-09 Terman David S Polymerized staphylococcal protein a for treatment of diseases
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
US5856452A (en) 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US7026446B1 (en) 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
GB9823071D0 (en) 1998-10-21 1998-12-16 Affibody Technology Ab A method
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
US6602977B1 (en) 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
EP2017343A3 (en) 1999-05-15 2009-01-28 University of California, San Diego Protein A based binding domains with desirable activities
US7163686B1 (en) 1999-05-15 2007-01-16 The Regents Of The University Of California Protein A based binding domains with desirable activities
EP3960855A1 (en) 2001-12-28 2022-03-02 Chugai Seiyaku Kabushiki Kaisha Method for stabilizing proteins
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
US7083948B1 (en) 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
JP4871126B2 (ja) 2003-07-04 2012-02-08 アフィボディ・アーベー Her2に対する結合親和性を有するポリペプチド
US7956165B2 (en) 2003-07-24 2011-06-07 Affisink Biotechnology Ltd. Compositions and methods for purifying and crystallizing molecules of interest
AU2004278311A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
EP1564286A1 (en) * 2004-02-11 2005-08-17 Université de Liège Hybrid proteins of beta-lactamase class A
US8597908B2 (en) 2004-07-06 2013-12-03 Kaneka Corporation Process for producing protein A-like protein with use of Brevibacillus genus bacterium
US8728828B2 (en) 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
US20080254551A1 (en) 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
EP1869071B1 (en) 2005-03-01 2010-12-01 Affibody AB Tnf-alpha binding polypeptide, uses thereof and methods employing it
JP2006304633A (ja) 2005-04-26 2006-11-09 Apro Life Science Institute Inc イムノグロブリン結合タンパク質
CN101213211A (zh) * 2005-06-17 2008-07-02 惠氏公司 纯化含Fc区蛋白的方法
WO2007014591A1 (de) 2005-08-03 2007-02-08 Merck Patent Gmbh Hydrophiles vernetztes polymer
CN102989018A (zh) 2005-08-03 2013-03-27 Rq生物科技有限公司 用于诊断IgA和IgM介导的肾脏疾病的方法和组合物
US8440191B2 (en) 2005-11-18 2013-05-14 Tufts Medical Center Clearance of abnormal IGA1 in IGA1 deposition diseases
CN103028380B (zh) 2006-01-06 2015-08-19 Emd密理博公司 亲和层析基质及其制备和使用方法
EP1992692B1 (en) 2006-02-21 2013-01-09 Protenova Co., Ltd. Immunoglobulin affinity ligand
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
GB0610776D0 (en) 2006-05-31 2006-07-12 Univ Bath Novel applications for staphylococcus aureus Sbi protein
EP2066419B1 (en) * 2006-09-29 2015-11-11 GE Healthcare Bio-Sciences AB Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation
JP5004165B2 (ja) 2006-10-10 2012-08-22 独立行政法人産業技術総合研究所 タンパク質の配向制御固定化に適したタンパク質
US7691608B2 (en) 2006-12-06 2010-04-06 Repligen Corporation Nucleic acids encoding recombinant protein A
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
KR101431856B1 (ko) 2007-01-22 2014-08-27 제넨테크, 인크. 항체의 고분자전해질 침전 및 정제
JP2008266221A (ja) 2007-04-20 2008-11-06 National Institute Of Advanced Industrial & Technology アミノ末端1箇所で配向制御固定化された固定化タンパク質
JP5522723B2 (ja) 2007-05-21 2014-06-18 ノマディックバイオサイエンス株式会社 新規ポリペプチド,アフィニティークロマトグラフィー用材,及びイムノグロブリンの分離及び/又は精製方法
SG149759A1 (en) 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
JP2009071766A (ja) 2007-09-18 2009-04-02 Panasonic Corp 受信端末装置
JP2011523408A (ja) 2008-05-15 2011-08-11 ノボ・ノルデイスク・エー/エス 抗体精製方法
JP5677943B2 (ja) 2008-06-05 2015-02-25 アフィボディ・アーベーAffibody Ab ポリペプチド
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
US20120149875A1 (en) 2009-01-12 2012-06-14 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
EP2412809B1 (en) 2009-03-24 2017-08-09 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
EP2646126A4 (en) * 2010-11-29 2014-12-17 Ge Healthcare Bio Sciences Ab affinity chromatography
WO2012087230A1 (en) 2010-12-20 2012-06-28 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
EP2690173B1 (en) * 2011-03-25 2019-07-03 Kaneka Corporation Protein for affinity-separation matrix
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands

Similar Documents

Publication Publication Date Title
JP2014193892A5 (OSRAM)
JP2013172734A5 (OSRAM)
JP2017048194A5 (OSRAM)
JP2014132019A5 (OSRAM)
JP2015212284A5 (OSRAM)
EP3670536A3 (en) Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
HRP20220531T1 (hr) Varijabilni fragmenti antitijela koji se umeću i modificirane a1-a2 domene nkg2d liganda
HK1200842A1 (en) Proteins with improved half-life and other properties
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
JP2015525217A5 (OSRAM)
JP2017518072A5 (OSRAM)
JP2015514395A5 (OSRAM)
JP2014501510A5 (OSRAM)
JP2014224126A5 (OSRAM)
WO2016071376A3 (en) Fc-region variants with modified fcrn-binding and methods of use
WO2017085172A3 (en) Improved serum albumin binders
EA202090216A3 (ru) Связывающие сывороточный альбумин домены фибронектина iii типа
WO2013184938A3 (en) Fusion polypeptides comprising mucin-domain polypeptide linkers
EP3210625A3 (en) Therapeutic peptides comprising antibodies binding to mhc class 1 polypeptide related sequence a (mica)
MX2012000765A (es) Dominios variables sencillos de union de albumina anti-suero mejorados.
JP2014043446A5 (OSRAM)
EP2552957A4 (en) ANTIBODIES WITH REINFORCED OR SUPPRESSIVE ACTIVE FUNCTION
MX2021000030A (es) Metodos y composiciones que utilizan polipeptidos variantes klotho.
JP2018504911A5 (OSRAM)
WO2015092335A3 (fr) Proteines recombinantes possedant une activite de facteur h